11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla
    Journal Article

    Mazaheri, Y.; Shukla-Dave, A.; Goldman, D. A.; Moskowitz, C. S.; Takeda, T.; Reuter, V. E.; Akin, O.; Hricak, H.
    Magnetic Resonance Imaging (2019)

    Fulltext@MSK | Save
  • The IARC perspective on colorectal cancer screening
    Editorial

    Lauby‐Secretan, B.; Vilahur, N.; Bianchini, F.; Guha, N.; Straif, K.; for the International Agency for Research on Cancer Handbook Working Group
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Assessing and treating tobacco use in lung cancer care
    Book Section

    Ostroff, J. S.; Park, E. R.
    In Pass, H. I.; Ball, D.; Scagliotti, G. V. (Eds.) IASLC Thoracic Oncology. 2nd ed (2018)

    Fulltext@MSK | Save
  • Impact of survivorship care plans (SCPs) on adherence to surveillance for second malignant neoplasms (SMNs) and cardiac dysfunction in the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Yan, A. P.; Chen, Y.; Hudson, M. M.; Gibson, T. M.; Neglia, J. P.; Oeffinger, K. C.; Leisenring, W. M.; Ness, K. K.; Ford, J.; Henderson, T. O.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases
    Meeting Abstract

    Tung, N. M.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Armstrong, A. C.; Conte, P. F.; Wu, W.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis
    Meeting Abstract

    Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Tonorezos, E. S.; Ford, J.; Wang, L.; Ness, K. K.; Yasui, Y.; Leisenring, W. M.; Sklar, C. A.; Robison, L. L.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save